SÜDPACK Medica presents PharmaGuard at CPHI in Barcelona
SÜDPACK customers also benefit when it comes to processing PharmaGuard
SÜDPACK customers also benefit when it comes to processing PharmaGuard
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Subscribe To Our Newsletter & Stay Updated